Clopidogrel use in children

Journal of Pediatrics

Volumn 147, Issue 5, 2005, Pages 657-661

  Finkelstein, Yaron ^c   Nurmohamed, Laila ^d   Avner, Marina ^d   Benson, Lee N ^d   Koren, Gideon ^a,b  

^a CANADIAN INSTITUTES OF HEALTH RESEARCH   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; ENOXAPARIN; HEPARIN; INOTROPIC AGENT; TISSUE PLASMINOGEN ACTIVATOR; VITAMIN K GROUP; WARFARIN;

ADOLESCENT; CANADA; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; GASTROINTESTINAL HEMORRHAGE; HEART DISEASE; HUMAN; INFANT; PRIORITY JOURNAL; RASH; REVIEW; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT OUTCOME;

EID: 27744583103     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2005.05.006     Document Type: Article

References (19)

1. R. Vitiello, B.W. McCrindle, D. Nykanen, R.M. Freedom, and L.N. Benson Complications associated with pediatric cardiac catheterization J Am Coll Cardiol 32 1998 1433 1440
2. J.L. Orford, P. Fasseas, S. Melby, K. Burger, S.R. Steinhubl, and D.R. Holmes Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation Am Heart J 147 2004 463 467
3. M.L. Jacobs, K.K. Pourmaghadan, E.M. Geary, A.T. Reyes, N. Madan, and L.B. McGrath Fontan's operation. Is aspirin enough? Is coumadin too much? Ann Thorac Surg 73 2002 64 68
4. G.B. Segel, and C.W. Francis Anticoagulant proteins in childhood venous and arterial thrombosis: a review Blood Cells Mol Dis 26 2000 540 560
5. U. Nowak-Gottl, A. Kosch, and N. Schlegel Thromboembolism in newborns, infants and children Thromb Haemost 86 2001 464 474
6. V. Price, and M.P. Massicotte Arterial thromboembolism in the pediatric population Semin Thromb Hemost 29 2003 557 565
7. R.G. Lerner, W.H. Frishman, and K.T. Mohan Clopidogrel: a new antiplatelet drug Heart Dis 2 2000 168 173
8. CAPRIE Steering Committee A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk for ischaemic events (CAPRIE) Lancet 348 1996 1329 1339
9. The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) trial investigators Effects of clopidogrel in addition to aspirin in patients with acute coronary syndrome without ST-segment elevation N Engl J Med 345 2001 494 502
10. H. Anzai, J. Child, B. Natterson, J. Krivokapich, M.C. Fishbein, and V.K. Chan Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices Am J Cardiol 93 2004 426 431
11. D. Lacroix, M. Sonnier, A. Moncoin, G. Cheron, and T. Cresteil Expression of CYP3A in the human liver: evidence that the shift between CYP3A7 occurs immediately after birth Eur J Biochem 247 1997 625 634
12. H.J. Willens Clopidogrel-induced mixed hepatocellular and cholestatic liver injury Am J Ther 7 2000 317 318
13. W.C. Lau, P.A. Gurbel, P.B. Watkins, C.J. Neer, A.S. Hopp, and D.G. Carville Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance Circulation 109 2004 166 171
14. T.A. Clarke, and L.A. Waskell The metabolism of clopidogrel is catalyzed by cytochrome P450 3A and is inhibited by atorvastatin Drug Metab Dispos 31 2003 53 59
15. S. Matetzky, B. Shenkman, V. Guetta, M. Shechter, R. Bienart, and I. Goldenberg Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction Circulation 109 2004 3171 3175
16. G.G. Biondi-Zoccai, P. Agostoni, L. Testa, A. Abbate, Q. Parisi, and F. Burzotta Increased mortality after coronary stenting in patients treated with clopidogrel without loading dose: evidence from a meta-analysis Minerva Cardioangiol 52 2004 195 208
17. D.J. Angiolillo, A. Fernandez-Ortiz, E. Bernardo, C. Ramirez, C. Barrera-Ramirez, and M. Sabate Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting Thromb Res 115 2005 101 108
18. J.S. Kim, K.S. Lee, Y.I. Kim, Y. Tamai, R. Nakahata, and H. Takami A randomized crossover comparative study of aspirin, cilostazol and clopidogrel in normal controls: analysis with quantitative bleeding time and platelet aggregation test J Clin Neurosci 11 2004 600 602
19. J.J. Thebault, G. Kieffer, G.D. Lowe, W.S. Nimmo, and R. Cariou Repeated-dose pharmacodynamics of clopidogrel in healthy subjects Semin Thromb Hemost 25 Suppl 2 1999 9 14